Course of cognitive decline in hematopoietic stem cell transplantation: A within-subjects design

Archives of Clinical Neuropsychology

Volumn 24, Issue 7, 2009, Pages 689-698

  Friedman, Melissa A ^a   Fernandez, Mercedes ^b   Wefel, Jeffrey S ^c   Myszka, Katherine A ^c   Champlin, Richard E ^c   Meyers, Christina A ^c  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; Cognition; Hematologic malignancy; Neuropsychology; Neurotoxicity; Treatment effects

Indexed keywords

ADULT; APTITUDE TEST; ARTICLE; COGNITIVE DEFECT; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGY; NEUROTOXICITY; PSYCHOMOTOR PERFORMANCE; RATING SCALE; RELIABLE CHANGE INDEX;

EID: 72949097607     PISSN: 08876177     EISSN: 18735843     Source Type: Journal    
DOI: 10.1093/arclin/acp060     Document Type: Article

References (55)

1. Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature reviews. Cancer, 7, 192-201.
2. Ahles, T. A., Saykin, A. J., Noll, W. W., Furstenberg, C. T., Guerin, S., Cole, B., et al. (2003). The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psycho-Oncology, 12, 612-619.
3. Ahles, T. A., Tope, D. M., Furstenberg, C., Hahn, D., & Mills, L. (1996). Psychologic and neuropsychologic impact of autologous bone marrow transplantation. Journal of Clinical Oncology, 14, 1457-1462.
4. Andrykowski, M. A. (1994). Psychosocial factors in bone marrow transplantation: A review and recommendations for research. Bone Marrow Transplant, 13, 357-375.
5. Andrykowski, M. A., Altmaier, E. M., Barnett, R. L., Burish, T. G., Gingrich, R., & Henslee-Downey, P. J. (1990). Cognitive dysfunction in adult survivors of allogeneic bone marrow transplantation: Relationship to dose of total body irradiation. Bone Marrow Transplant, 6, 269-276.
6. Andrykowski, M. A., Schmitt, F. A., Gregg, M. E., Brady, M. J., Lamb, D. G., & Henslee-Downey, P. J. (1992). Neuropsychologic impairment in adult bone marrow transplant candidates. Cancer, 70, 2288-2297.
7. Beck, A. T. (1987). Beck depression inventory. San Antonio, TX: The Psychological Corporation.
8. Beglinger, L. J., Duff, K., Van Der Heiden, S., Moser, D. J., Bayless, J. D., Paulsen, J. S., et al. (2007). Neuropsychological and psychiatric functioning pre- and posthematopoietic stem cell transplantation in adult patients: A preliminary study. Journal of the International Neuropsychological Society, 13, 172-177.
9. Beglinger, L. J., Gaydos, B., Tangphao-Daniels, O., Duff, K., Kareken, D. A., Crawford, J., et al. (2005). Practice effects and the use of alternate forms in serial neuropsychological testing. Archives of Clinical Neuropsychology, 20, 517-529.
10. Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998). Hopkins Verbal Learning Test-Revised: Normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist, 12, 43-55.
11. Benedict, R. H. B., & Zgaljardic, D. J. (1998). Practice effects during repeated administrations of memory tests with and without alternate forms. Journal of Clinical and Experimental Neuropsychology, 20, 339-352.
12. Benton, A. L., & Hamsher, K. de S. (1983). Multilingual aphasia examination. Iowa City, IA: AJA Associates.
13. Benton, A. L., & Hamsher, K. de S. (1989). Multilingual aphasia examination manual. Iowa City, IA: AJA Associates.
14. Benton, A. L., Hamsher, K. de S., & Sivan, A. B. (1994). Multilingual aphasia examination. Iowa City, IA: AJA Associates.
15. Booth-Jones, M., Jacbosen, P. B., Ransom, & Soety, E. (2005). Characteristics and correlates of cognitive functioning following bone marrow transplantation. Bone Marrow Transplantation, 36, 695-702. (Pubitemid 41518712)
16. Brandt, J. (1991). The Hopkins Verbal Learning Test: Development of a new verbal memory test with six equivalent forms. The Clinical Neuropsychologist, 5, 125-142.
17. Chelune, G. J., Naugle, R. I., Luders, H., Sedlak, J., & Awad, I. A. (1993). Individual change after epilepsy surgery: Practice effects and base-rate information. Neuropsychology, 7, 41-52.
18. Dikmen, S., Heaton, R. K., Grant, I., & Temkin, N. R. (1999). Test-retest reliability and practice effects of expanded Halstead-Reitan neuropsychological test battery. Journal of the International Neuropsychological Society, 5, 346-356.
19. Fann, J. R., Roth-Roemer, S., & Burington, B. E. (2002). Delirium in patients undergoing hematopoietic stem cell transplantation. Cancer, 95, 1971-1981.
20. Fromm-Auch, D., & Yeudall, L.T. (1983). Normative data for the Halstead-Reitan neuropsychological tests. Jounral of Clinical Neuropsychology, 5, 221-238.
21. Garrick, R. (2000). Neurologic complications. In K. Atkinson (Ed.), Clinical bone marrow and blood stem cell transplantation. Cambridge, UK: Cambridge University Press.
22. Harder, H., Cornelissen, J. J., Van Gool, A. R., Duivenvoorden, H.J., Eijkenboom,W.M., & van den Bent, M.J. (2002). Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer, 95, 183-192.
23. Harder, H., Duivenvoorden, H. J., van Gool, A. R., Cornelissen, J. J., & van den Bent, M.J. (2006). Neurocognitive functions and quality of life in haematological patients receiving haematopoietic stem cell grafts: A one-year follow-up pilot study. Journal of Clinical and Experimental Neuropsychology, 28, 283-293.
24. Harder, H., van Gool, A. R., Cornelissen, J. J., Duivenvoorden, H.J., Eijkenboom, W.M., Barge, R.M., et al. (2005). Assessment of pre-treatment cognitive performance in adult bone marrow or haematopoietic stem cell transplantation patients: A comparative study. European Journal of Cancer, 41, 1007-1016.
25. Ingraham, L. J., & Aiken, C. G. (1996). An empirical approach to determining criteria for abnormality in test batteries with multiple measures. Neuropsychology, 10, 120-124.
26. Jacobs, S. R., Small, B. J., Booth-Jones, M., Jacobsen, P. B., & Fields, K. K. (2007). Changes in cognitive functioning in the year after hematopoietic stem cell transplantation. Cancer, 110, 1560-1567.
27. Jacobsen, P. B., Garland, L. L., Booth-Jones, M., Donovan, KA, Thors, CL, Winters, E., et al. (2004). Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. Journal of Pain and Symptom Management, 28, 7-18.
28. Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12-19.
29. Lezak, M. D. (1995). Neuropsychological Assessment. New York: Oxford University Press.
30. Lezak, M. D., Howieson, D., & Loring, D. (2004). Neuropsychological Assessment (4th ed.). New York, NY: Oxford University Press.
31. McQuellon, R. P., Russell, G. B., Cella, D. F., Craven, B. L., Brady, M., Bonomi, A., et al. (1997). Quality of life measurement in bone marrow transplantation: Development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation (FACT-BMT) scale. Bone Marrow Transplantation, 19, 357-368.
32. McSweeny, A. J., Naugle, R. I., Chelune, G. J., Luders, H., et al. (2003). "T scores for change": An illustration of a regression approach to depicting change in clinical neuropsychology. The Clinical Neuropsychologist, 7, 300-312.
33. Meyers, C. A. (1994). Neuropsychological aspects of cancer and cancer treatment. Physical Medicine and Rehabilitation: State of the Art Reviews, 8, 229-241.
34. Meyers, C. A. (2000). Neurocognitive dysfunction in cancer patients. Oncology, 14, 75-81.
35. Meyers, C. A., & Abbruzzese, J. L. (1992). Cognitive functioning in cancer patients: Effect of previous treatment. Neurology, 42, 434-436.
36. Meyers, C. A., Albitar, M., & Estey, E. (2005). Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer, 104, 788-793.
37. Meyers, C. A., Byrne, K. S., & Komaki, R. (1995). Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer, 12, 231-235.
38. Meyers, C. A., & Valentine, A. D. (1995). Neurological and psychiatric adverse effects of immunological therapy. CNS Drugs, 3, 56-68.
39. Meyers, C. A., Weitzner, M., Byrne, K., Valentine, A., Champlin, R. E., & Przepiorka, D. (1994). Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. Journal of Clinical Oncology, 12, 820-826.
40. Padovan, C. S., Yousry, T. A., Schleuning, M., Holler, E., Kolb, H.-J., & Straube, A. (1998). Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Annals of Neurology, 43, 627-633.
41. Pavol, M. A., Meyers, C. A., Rexer, J. L., Valentine, A. D., Mattis, P. J., & Talpaz, M. (1995). Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia. Neurology, 45, 947-950.
42. Peper, M., Steinvorth, S., Schraube, P., Fruehauf, S., Haas, R., Kimmig, B.N., et al. (2000). Neurobehavioral toxicity of total body irradiation: A follow-up in long-term survivors. International Journal Radiation Oncology, Biology, Physics, 46, 303-311.
43. Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Hack, M., Morag, A., et al. (2001). Cytokine-associated emotional and cognitive disturbances in humans. Archives of General Psychiatry, 58, 445-452.
44. Reitan, R. M. (1958). Validity of the Trail Making Test as an indication of organic brain damage. Perceptual and Motor Skills, 8, 271-276.
45. Richard, F., & Amouyel, P. (2001). Genetic susceptibility factors for Alzheimer's disease. European Journal of Pharmacology, 412, 1-12.
46. Spielberger, C., Gorsuch, R., & Lushene, R. (1970). State-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press.
47. Syrjala, K. L., Dikmen, S., Langer, S. L., Roth-Roemer, S., & Abrams, J. R. (2004). Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood, 104, 3386-3392.
48. Temkin, N. R., Heaton, R. K., Grant, I., Dikmen, S.S., et al. (1999). Detecting significant change in neuropsychological test performance: A comparison of four models. Journal of the International Neuropsychological Society, 5, 357-369.
49. Valentine, A. D., & Meyers, C. A. (2001). Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer, 92(Suppl. 6), 1694-1698.
50. Wechsler, D. (1981). Wechsler adult intelligence scale-revised. San Antonio, TX: The Psychological Corporation.
51. Wefel, J. S., Lenzi, R., Theriault, R., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004). "Chemobrain" in breast cancer? A prologue. Cancer, 101, 466-475.
52. Wefel, J. S., Lenzi, R., Theriault, R., Davis, R. N., & Meyers, C. A. (2004). The cognitive sequelae of standard dose adjuvant chemotherapy in women with breast cancer: Results of a prospective, randomized, longitudinal trial. Cancer, 100, 2292-2299.
53. Wenz, F., Steinvorth, S., Lohr, F., Fruehauf, S., Wildermuth, S., van Kampen, M., et al. (2000). Prospective evaluation of delayed central nervous system (CNS) toxicity of hyperfractionated total body irradiation (TBI). International Journal of Radiation Oncology, Biology, Physics, 48, 1497-1501.
54. Wilson, B. A., Watson, P. C., Baddeley, A. D., Emslie, H., & Evans, J.J. (2000). Improvement or simply practice? The effects of twenty repeated assessments on people with and without brain injury. Journal of the International Neuropsychological Society, 6, 469-479.
55. Winer, B. J., Brown, D. R., & Michels, K. M. (1991). Statistical principles in experimental design (3rd ed.). New York: McGraw-Hill.